Patients at high risk for a severe clinical course of COVID-19 — small-area data in support of vaccination and other population-based interventions in Germany
Jakob Holstiege(Siemens Healthineers (Germany)), Jörg Bätzing(Central Research Institute of Epidemiology)
Cited by 10